Mr. Pearson is currently Chief Executive Officer of Carrick Therapeutics, a privately held biopharmaceutical company focusing on the innovative research and development of transformative oncology medicines. He previously served as Chief Financial Officer and Executive Vice President for TESARO, Inc., a publicly held oncology-focused biopharmaceutical company. Previous positions include EVP and CFO at Catalyst Health Solutions, a publicly held pharmacy benefit manager with over $5bn in revenues, and EVP and CFO at MedImmune, where he had functional responsibility for finance, information technology, strategic planning and governance. Mr. Pearson presently is a member of the Board of Directors of Ra Pharmaceuticals. He is a CPA, holds B.S. degrees in Business Administration from the University of Delaware and in Accounting from the University of Maryland University College, and an M.S. in Finance from Loyola University.